ClinicalTrials.gg
CompletedNCT04381442Updated May 8, 2020

Effect of Low Level Laser on Orthodontic Canine Retraction

An interventional study of Low Level Laser Therapy in Dental Malocclusion, sponsored by Al-Azhar University. Completed. Open to participants aged 15 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-08.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Oct 2016, registered May 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
15 Years to 25 Years
Sex
All
01

Study summary

The aim of this study was to determine whether orthodontically moved maxillary canines exposed to two different protocols and dosage of LLLT exhibited differences in amount and rate of orthodontic tooth movement.

Read the detailed description

Fifteen orthodontic patients, 12 females and 3males, with a mean age of 17.48 ± 2.95 years were included. They had a clinical indication for bilateral extraction of at least first maxillary premolars. Using a split mouth design, maxillary left and right sides were randomly divided into two groups. In group 1, LLLT was delivered at 10 points; 5 from buccal and 5 from palatal aspects with a total dose of 8 Joule (J) per session that distributed as follows; 2 cervical, 1 middle, 2 apical. In group II, laser was applied from buccal side only at 5 points through the same order with a dose of 4 J per session. In both protocols, maxillary canines were irradiated with a gallium aluminum-arsenide diode laser in continuous mode with 635 nm, 100 mW, 25 J/cm2, 8 seconds/ point, 0.8 J/point. Both sides were distalized by a standard protocol with uniform 150 gm retraction force via a nickel-titanium closed coil spring. In both protocols, laser regimen was applied on days 0, 3, 7, and 14 in the 1st month, and thereafter on every 15th day until 6-month observation period of canine retraction phase. Amount and monthly rate of maxillary canine retraction and degree of anchorage loss were determined by direct intraoral and indirect 3D digital models measurements. Evaluations were undertaken immediately before initiating retraction (T0), after 4 weeks (T1), after 8 weeks (T2), after 12 weeks (T3), after 16 weeks (T4), after 20 weeks (T5), and after 24 weeks (T6). Significance level was set at p \< 0.05.

02

Conditions studied

  • Dental Malocclusion

Browse trials for

Keywords

  • Low Level Laser Therapy
  • Orthodontic Tooth movement
  • Canine Retraction
  • Two Protocols and Energy Doses
03

In context

Malocclusion

469 studies on the registry are indexed under Malocclusion; 91 are open to participants now.

This study's enrollment of 15 is below the median of 36 across 383 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

Al-Azhar University is the lead sponsor of 525 studies on the registry; 171 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Complete permanent dentition (3rd molars excluded).
  • The age was ranged from 15 -25 years.
  • Malocclusion that required extraction of at least maxillary first premolars, followed by canine retraction.
  • Good oral hygiene and periodontal health.

Exclusion criteria

Exclusion Criteria:

  • Patients who diagnosed to have an indication for non-extraction approach.
  • Serious systemic diseases and/or long term medications that could interfere with OTM.
  • Previous orthodontic treatment.
  • Poor oral hygiene or periodontally compromised patients.
  • Craniofacial anomalies or history of parafunctional habits.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Buccal &palatal low level laser therapy

    In group I,low level laser therapy was delivered at 10 points; 5 from buccal and 5 from palatal aspects with a total dose of 8 Joule (J) per session that distributed as follows; 2 cervical, 1 middle, 2 apical. Maxillary canines were irradiated with a gallium aluminum-arsenide diode laser in continuous mode with 635 nm, 100 mW, 25 J/cm2, 8 seconds/ point, 0.8 J/point.Maxillary canines were distalized by a standard protocol with uniform 150 gm retraction force via a nickel-titanium closed coil spring.Laser regimen was applied on days 0, 3, 7, and 14 in the 1st month, and thereafter on every 15th day until 6-month observation period of canine retraction phase.

    Radiation: Low Level Laser Therapy

  • Active comparator
    Buccal low level laser therapy

    In group II, low level laser therapy was delivered at 5 points; from buccal palatal aspects only with a total dose of 4 Joule (J) per session that distributed as follows; 2 cervical, 1 middle, 2 apical. Maxillary canines were irradiated with a gallium aluminum-arsenide diode laser in continuous mode with 635 nm, 100 mW, 25 J/cm2, 8 seconds/ point, 0.8 J/point.Maxillary canines were distalized by a standard protocol with uniform 150 gm retraction force via a nickel-titanium closed coil spring.Laser regimen was applied on days 0, 3, 7, and 14 in the 1st month, and thereafter on every 15th day until 6-month observation period of canine retraction phase.

    Radiation: Low Level Laser Therapy

Interventions

  • RadiationLow Level Laser Therapy

    Also known as: Photobiomodulation

06

What researchers measure

Primary outcomes

  1. Evaluation the rate of maxillary canine retraction

    Evaluation and comparison of amount and monthly rate of distal movement of maxillary canine, in both groups, that were determined by direct intraoral measurements and indirect measurements of 3D scanned study models

    Time frame: 6 Months

Secondary outcomes

  1. Evaluation of anchorage loss

    Evaluation and comparison of the amount of maxillary molar mesial movement (anchorage loss) between both groups via study models assessment.

    Time frame: 6 Months

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2016 to primary completion in Jun 2018, 19 months.

Of 260 non-industry interventional studies with no phase under Malocclusion, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 25. This study's 19 months is above that.

Counting every sponsor, half of 272 studies reached it within 15 months; a quarter within 10 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2020
First posted
May 8, 2020
StartActual
Oct 15, 2016
Primary completionActual
Jun 10, 2018
CompletionActual
Feb 24, 2019
Last update
May 8, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04381442
Responsible party
Abdullah Mohammed Yahya Al-Haj (Postgraduate MSc. Student, Department of Orthodontics, Faculty of Dental Medicine (Boys), Al-Azhar University, Cairo, Egypt, Dentist, Ministry of Health, Yemen., Al-Azhar University) — Principal investigator
First posted
May 8, 2020
Start date
Oct 15, 2016
Primary completion
Jun 10, 2018
Completion
Feb 24, 2019
Last update
May 8, 2020

Study contacts

Abdullah M Al-Haj, MSc student
principal investigator · Al-Azhar University
Farouk A Hussein, Ass.Prof
study director · Al-Azhar University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion